OG article by Kyle Jaeger December 16, 2025 A recent poll conducted by NuggMD in collaboration with Marijuana Moment indicates that merely six percent of marijuana consumers approve of the Trump administration’s actions on cannabis policy, with 1.6 percent strongly approving and 4.5 percent approving. In contrast, 38.4 percent remain neutral, 26.1 percent disapprove, and 29.5 percent strongly disapprove, resulting in a net approval rating of -49.6 percent. This figure repres

OG article by Rachelle Gordon December 16, 2025 President Trump directly addressed circulating rumors regarding cannabis reform during a White House press conference held on Monday. When questioned by a journalist about a recent report indicating his readiness to instruct the administration to reclassify cannabis from Schedule I to Schedule III, Trump acknowledged ongoing discussions within the White House. He remarked, “A lot of people want to see it, the reclassification,

OG article by Tessa Koumoundouros December 16, 2025 A groundbreaking study utilizing an engineered rabies virus in mice has uncovered how psilocybin, the active compound in magic mushrooms, disrupts depressive cycles by fundamentally rewiring brain connections. Researchers tracked neural alterations following a single dose, observing heightened connectivity between regions responsible for sensory processing and those governing actions, while diminishing feedback loops in the

OG article by Max Rego December 16, 2025 Republican Representative Mike Lawler from New York declared on Monday that it would be incorrect for President Trump to proceed with reclassifying marijuana, deeming the action ill-advised. During an interview with Blake Burman on NewsNation’s “The Hill,” Lawler characterized marijuana as a gateway drug, arguing that the majority of people who progress to harder substances start with marijuana. He stressed that rescheduling the subst

OG article by HACC, Central Pennsylvania’s Community College, December 16, 2025 HACC, Central Pennsylvania’s Community College, in partnership with Green Flower, the leading provider of cannabis education, has announced the launch of a new suite of online cannabis career certificate programs. These updated programs feature contributions from over 50 cannabis industry leaders and subject matter experts, offering refreshed course content, accessible pricing, and comprehensive

OG article by Michael Kudrewicz, Guest Columnist December 16, 2025 As legalization expands and regulated cannabis markets mature, a critical vulnerability arises in the supply chain: unstable and poorly sourced genetics. The $32 billion legal industry has pivoted from reliable cultivars to novel strains emphasizing unique appearances, catchy names, or ultra-high THC content. However, the sector's future hinges on heritage genetics like Blue Dream, Trainwreck, and Sour Diesel

OG article  by Mack Shaw December 13, 2025 Texas Original has opened a new 75,000-square-foot medical marijuana facility in Bastrop, Texas, nearly ten times larger than its previous 7,700-square-foot headquarters. Located at 176 FM 969, the facility integrates cultivation in a hybrid greenhouse, manufacturing labs for extraction and processing, testing labs, packaging, dispensing, distribution, and delivery logistics. This expansion aligns with House Bill 46, recently passed

OG article  by Anthony Martinelli December 13, 2025 U.S. House Speaker Mike Johnson privately informed GOP leadership that he opposes President Trump's plan to reschedule marijuana from Schedule I to Schedule III under federal law. During a leadership meeting convened after Johnson's call with Trump on Wednesday, he relayed the president's intent to issue an executive order on the matter. The meeting included Majority Leader Steve Scalise, Majority Whip Tom Emmer, and several

OG article  by Anthony Martinelli December 13, 2025 The U.S. Supreme Court has declined to hear the case Canna Provisions Inc. v. Bondi, as noted in the Court's December Orders List, effectively maintaining federal marijuana prohibition without intervention. This decision ends expectations that the justices would tackle the conflict between nationwide federal bans and state-legalized marijuana markets, where most states have legalized it for medical or recreational use. The c

OG article  by Graham Abbott December 13, 2025 New York Governor Kathy Hochul has requested the resignation of Felicia A.B. Reid, the Acting Executive Director of the Office of Cannabis Management (OCM). Reid stepped down immediately on Monday, following the OCM's last-minute withdrawal of an investigation into Long Island-based licensee Omnium Health. The probe accused the company of illegally renting its license and space to unrelated entities, allowing unlicensed cannabis

OG article  by Kit Norton December 13, 2025 Marijuana stocks rose on Friday amid reports that President Donald Trump plans to issue an executive order easing federal restrictions on marijuana. According to The Washington Post, citing six sources familiar with the talks, Trump has discussed reducing oversight of marijuana products to match that of certain prescription painkillers. However, the stocks declined on Monday following this news. The report surfaced late Thursday, sp

OG article by Marijuana Moment Alabama officials have taken a major step forward in their medical cannabis program by approving three dispensary licenses, setting the stage for sales to begin in 2026. The Alabama Medical Cannabis Commission granted licenses to GP6 Wellness, RJK Holdings, and CCS of Alabama, with the fourth license to follow in late January due to an administrative law judge's recommendation. These approvals come nearly five years after the 2021 legislation e